Anemia, Aplastic
5 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.
Broader: Anemia, Bone Marrow Failure Disorders, Hematologic Diseases
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Isatuximab for anemia, aplastic | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| reduced-dose conditioning regimen containing TBI in hematopoietic stem cell transplantation treating elderly patients with aplastic anemia for anemia, aplastic | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Rivogenlecleucel + rimiducid for anemia, aplastic | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Romiplostim for anemia, aplastic | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| thrombopoietin receptor agonist (TPO-RA) + Cyclosporine + ROMIPLOSTIM for anemia, aplastic | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.